Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fisk

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
BMJ Open|June 9, 2023
Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional studyShaza Almweisheer, Charles N Bernstein, Lesley A Graff, et al.
Expert Review of Neurotherapeutics|November 4, 2020
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare settingHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Journal of Neurology|February 3, 2011
Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's diseaseTyler M Rolheiser, Heather G Fulton, Kimberley P Good, et al.
Neurology|March 6, 2016
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosisTingting Zhang, Helen Tremlett, Stella Leung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2023
Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosisRuth Ann Marrie, Charles N Bernstein, Casandra Dolovich, et al.
International Journal of MS Care|April 20, 2018
Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple SclerosisRuth Ann Marrie, Scott B Patten, Lindsay I Berrigan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2021
Disease-modifying drugs for multiple sclerosis and subsequent health service useHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Neurology|January 5, 2018
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu, et al.
Chembiochem : a European Journal of Chemical Biology|September 14, 2010
Live-cell imaging of cellular proteins by a strain-promoted azide-alkyne cycloadditionKimberly E Beatty, John D Fisk, Brian P Smart, et al.
Frontiers in Neurology|November 21, 2022
Sex and age differences in the Multiple Sclerosis prodromeFardowsa L A Yusuf, José M A Wijnands, Mohammad Ehsanul Karim, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
BMJ Open|June 9, 2023
Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional studyShaza Almweisheer, Charles N Bernstein, Lesley A Graff, et al.
Expert Review of Neurotherapeutics|November 4, 2020
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare settingHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Journal of Neurology|February 3, 2011
Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's diseaseTyler M Rolheiser, Heather G Fulton, Kimberley P Good, et al.
Neurology|March 6, 2016
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosisTingting Zhang, Helen Tremlett, Stella Leung, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2023
Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosisRuth Ann Marrie, Charles N Bernstein, Casandra Dolovich, et al.
International Journal of MS Care|April 20, 2018
Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple SclerosisRuth Ann Marrie, Scott B Patten, Lindsay I Berrigan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2021
Disease-modifying drugs for multiple sclerosis and subsequent health service useHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Neurology|January 5, 2018
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu, et al.
Chembiochem : a European Journal of Chemical Biology|September 14, 2010
Live-cell imaging of cellular proteins by a strain-promoted azide-alkyne cycloadditionKimberly E Beatty, John D Fisk, Brian P Smart, et al.
Frontiers in Neurology|November 21, 2022
Sex and age differences in the Multiple Sclerosis prodromeFardowsa L A Yusuf, José M A Wijnands, Mohammad Ehsanul Karim, et al.
Pageof 19